OR4C46 Activators
OR4C46 can initiate a cascade of intracellular events leading to its activation through various pathways. Cyclic AMP (cAMP) is central to these processes, as it serves as a secondary messenger that activates protein kinase A (PKA). When chemicals such as Forskolin are introduced, they directly stimulate adenylyl cyclase, thereby increasing the levels of cAMP within the cell. This rise in cAMP facilitates the activation of PKA, which can then phosphorylate target proteins, including G protein-coupled receptors (GPCRs) like OR4C46. Similarly, Isoproterenol, acting as a synthetic catecholamine, binds and activates beta-adrenergic receptors, which are linked to Gs proteins that also stimulate the production of cAMP. The enhanced cAMP levels subsequently activate PKA, which may target and activate OR4C46. The same effect on cAMP and PKA can be seen with the introduction of Epinephrine and Noradrenaline, both of which interact with adrenergic receptors, and Glucagon, which binds to its specific GPCR.
In addition to the catecholamines, other biomolecules that bind to various GPCRs can also influence the activation of OR4C46. Histamine, upon binding to its receptors, and Serotonin, through its interaction with serotonin receptors, can both activate pathways that lead to PKA-mediated phosphorylation of GPCRs. Dopamine and Adenosine, by binding to their respective receptors, follow a similar pattern by elevating cAMP and activating PKA, which in turn can phosphorylate OR4C46. Prostaglandin E2, engaging with its own GPCR, and Angiotensin II, through its receptor-stimulated phospholipase C pathway, can also contribute to signaling cascades involving PKA activation. Although these pathways are distinct, they converge on the common mechanism of PKA activation, which is a critical step in the phosphorylation and activation of OR4C46.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Cyclic AMP (cAMP) serves as a secondary messenger that activates protein kinase A (PKA). Once activated, PKA phosphorylates target proteins, including G protein-coupled receptors (GPCRs) like OR4C46, leading to their activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that binds and activates beta-adrenergic receptors, triggering a Gs protein-coupled receptor pathway. This pathway elevates cAMP and activates PKA, which can lead to the activation of related GPCRs such as OR4C46. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to and activate histamine receptors, which are GPCRs. This can lead to a cascade of intracellular events including the activation of PKA. PKA can phosphorylate and activate various GPCRs, potentially including OR4C46. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $530.00 | 3 | |
Serotonin can activate serotonin receptors, which are part of the GPCR family. This activation can stimulate pathways leading to the activation of PKA, which may phosphorylate and activate GPCRs like OR4C46. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to dopamine receptors, which are also GPCRs. Activation of these receptors can lead to increased cAMP and PKA activation. PKA then may activate other GPCRs in the same family as OR4C46 through phosphorylation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 binds to its GPCR and activates it, leading to downstream signaling events that can result in the activation of PKA. PKA may then activate GPCRs such as OR4C46 through phosphorylation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, causing a rise in cAMP levels and subsequent PKA activation. PKA can phosphorylate various proteins, including GPCRs, potentially leading to the activation of OR4C46. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine binds to its GPCR receptors to increase cAMP levels, which activate PKA. The PKA pathway may lead to the phosphorylation and activation of other GPCRs, such as OR4C46. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II binds to its GPCR to stimulate phospholipase C, which can lead to a signaling cascade involving PKA. PKA can then phosphorylate and potentially activate related GPCRs, including OR4C46. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Noradrenaline, another catecholamine, binds to adrenergic receptors, increasing cAMP and activating PKA. This activation could lead to the phosphorylation of GPCRs in the same family as OR4C46, resulting in its activation. | ||||||